Article
Identification of genetic risk for pancreatic adenocarcinoma.
Cancer genetics - 1 Nov 2015
Flores Kendra, Dinh Kate, Rouleau Erin, Whalen Giles, Wassef Wahid, LaFemina Jennifer
Abstract excerpt
Recent consortium guidelines support research-based screening for those at high risk of pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC)). Genetic testing plays an important role in the establishment of high-risk PDAC research clinics by delineating those individuals who would benefit from screening protocols. We retrospectively examined patients referred for PDAC-related genetic testing from January...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
